Impressum / Imprint

2cureX GmbH
(Tochtergesellschaft der 2curex AS / subsidiary of 2curex AS https://www.2curex.com/contact/)

Spectrum Building at UKE
Martinistraße 64
20251 Hamburg
Germany

Tel.: +49 173 6000 704
E-Mail: info@2curex.com

Verantwortlich für den Inhalt nach § 55 II RStV / Responsible for the content according to § 55 II RStV
Dr. Jürgen Kupper, Geschäftsführer

Vertreten durch / Represented by
Dr. Jürgen Kupper, Geschäftsführer

Gesellschafter / Shareholder
2cureX AS Vertreten durch / Represented by Prof. Ole Thastrup, Chief Executive Officer

Handelsregistereintrag / Commercial Register
HRB 137736, Amtsgericht Hamburg

Umsatzsteuer-ID-Nr. / VAT ID
DE303308758

Ausstellende Behörde / Issuing Authority
Hansestadt Hamburg

Upcoming events

May 24, 2022

Interim Report Q1 2022 released

View previous reports

May 24, 2022

Annual General Meeting

Watch past presentations

August 25, 2022

Interim Report Q2 2022 released

View previous reports

November 24, 2022

Interim Report Q3 2022 released

View previous reports

IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.